Nuvo Announces 2009 second quarter financial results
...d payments 132 216 264 366 Deferred stock unit expense 145 - 239 - accretion of interest on debentures 147 227 295 434 Other (273) 91 ...Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
... ---- --- ---- ----- ----- Net loss (17,806) (23,113) (37,109) (46,327) (237,284) accretion to redemption value of redeemable convertible preferred stock - - - - (78...Gen-Probe Reports Financial Results for Second Quarter 2009
...ivities: Depreciation and amortization 19,463 17,233 Amortization of premiums on investments, net of accretion of discounts 2,720 3,504 Stock-based compensation 11,405 9,228 Stock-based compen...WellPoint Reports Second Quarter 2009 Results
...n disposal of assets 0.9 0.5 Deferred income taxes 18.1 26.0 Amortization, net of accretion 225.0 238.2 Depreciation expense 52.3 51.9 Share-based compensation ...Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
...quity components of our convertible notes partially offset by the accretion of the reduced carrying values resulting from the recognition of ...erest expense recognized through December 31, 2008 related to the accretion of the reduced carrying values of our convertible notes and (ii) ...BELLUS Health reports results for first quarter of fiscal 2009
...ompared to the same period the previous year. accretion expense amounted to $1,282,000 for the current qua...$1,207,000 for the same quarter the previous year. accretion expense represents the imputed interest under GAAP...imited to: all debt would be presented as current, accretion on convertible notes would be accelerated, and the...Triple-S Management Corporation Reports First Quarter 2009 Results
...its current Board authorization. 2009 Guidance "We have raised our guidance for this year's earnings per share by $0.05 to reflect the accretion from our share repurchase program and adjusted the share count," said Ruiz-Comas. "All of our other performance metrics are tracking our prior expecta...Duane Reade Holdings, Inc. Reports First Quarter 2009 Results
...in July 2011. (7) The increase in the balance of the redeemable preferred stock and accrued dividends from December 27, 2008 is due to the accretion of the discount on the liability recorded for the preferred stock offering completed during the second quarter of 2007 and the ...Pharmasset Reports Fiscal Year End 2008 Financial Results
... - - NET LOSS (54,657,711) (5,064,648) (11,325,657) REDEEMABLE PREFERRED STOCK accretion - 1,775,684 1,110,973 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $(54,657,711) $(6,8...Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
... -------------------------- NET LOSS (15,028,443) (5,862,113) REDEEMABLE PREFERRED STOCK accretion - 1,204,653 -------------------------- NET LOSS ATTRIBUTABLE TO COMMON STOC...Amicus Therapeutics Announces Second Quarter 2008 Financial Results
...n expense -- Pre-tax charges for preferred stock accretion -- Pre-tax charges for changes in the fair value... - - (19,424) Preferred stock accretion (310) - (351) - ...k GAAP as Non-GAAP accretion Compensation Reported Income Statement Clas...Pharmasset Reports First Fiscal Quarter 2008 Financial Results
... ------------------------------ NET INCOME (LOSS) (12,172,599) 3,907,206 REDEEMABLE PREFERRED STOCK accretion - 284,197 ------------------------------ NET INCOME (...Vanda Pharmaceuticals Reports Third Quarter 2007 Results
...ock- based compensation 14,480,108 4,525,202 Loss on disposal of assets 27,017 29,528 accretion of discount on investments (1,315,609) (301,293) Changes in assets and liabilities: Prepaid expenses and other current assets ...Amicus Therapeutics Announces Second Quarter 2007 Financial Results
...4) - (19,424) Preferred stock accretion (41) (310) (81) (351) ...as Non-GAAP Liability accretion sation Reported Income Statement Classificati...6) (86) Preferred stock accretion - (310) (310) ...Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
... 32 72 47 Interest expense, including amortization of loan discount, deferred financing costs and accretion of beneficial conversion feature (280) (234) (1,508) (1,253) Preferred dividends (20) ¿ ...February 2009 Geology and GSA Today media highlights
...hesis. Integration of this stratum into the Neoproterozoic record of climate change also places constraints on the timing of basin formation and early accretion in Central Asia. Tails of two plume types in one mantle A. Lenardic and A.M. Jellinek, Department of Earth Science, MS 126, P.O. Box 1892, Rice...January GEOLOGY media highlights
...e. Repeated cycles of erosion around the rocks and subsequent rolling cause them to move and organize spatially. Evidence for focused magmatic accretion at segment centers from lateral dike injections captured beneath the Red Sea rift in Afar Derek Keir et al., School of Earth and Environment, Univ...September Geology and GSA Today media highlights
... Building, Chester Street, Manchester M1 5GD, UK. Pages 691-694. Perry et al.'s study presents a long-term (approximately 1200 year) record of reef accretion and coral community composition from a turbid-zone, nearshore reef on the inner shelf of the Great Barrier Reef, Australia, and examines long-term int...'Punctuated' evolution in the human genome
...plicated DNA sequences ?but only at specific time-points during evolution. It appears that long periods of genomic stasis, at least with regard to the accretion of duplicated DNA fragments, are "punctuated" by relatively brief episodes of duplicative activity. This is the first time that such temporal bias has...OncoGenex Reports Second Quarter 2009 Financial Results
...- ------------------ Net loss 4,563 2,168 6,972 3,825 Redeemable convertible preferred share accretion - 780 - 1556 ------------------ ------------------ Loss attributa...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... (13,623) (17,024) (26,095) (190,283) Deemed dividend - - - - (19,424) Preferred stock accretion - - - - (802) Net loss attributable to common stockholders $(9,294) $(13,623) $...Vasogen Announces Second Quarter 2009 Results
...tes payable - - - - (1,279) accretion in carrying value of senior convertible notes payable ...f patents - - (487) - (487) accretion in carrying value of senior convertible...Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
... Total other income (expense) (229) 770 6,009 Net loss (19,303) (23,214) (219,478) accretion to redemption value of redeemable convertible preferred stock - - (78) Deemed dividend of b...OncoGenex Reports First Quarter Financial Results
... (10) 214 Net loss 2,409 1,657 Redeemable convertible preferred share accretion - 776 ------------------------- Loss attributable to com...Vasogen Announces First Quarter 2009 Results
...onvertible notes payable - - (1,279) accretion in carrying value of senior convertible notes payable ...in on sale of patents (487) - (487) accretion in carrying value of senior convertible notes payable ...Gen-Probe Completes Acquisition of Tepnel Life Sciences
...robe, and (iii) the risk that Gen-Probe may not achieve its expected 2009 growth, revenue, earnings or other financial targets that are assumed in its accretion analysis. The foregoing list sets forth some, but not all, of the factors that could affect the Company's ability to achieve results described in any ...Vasogen Announces 2008 Year-End Results
...otes payable - (5) (930) (1,279) accretion in carrying value of senior convertible notes payable ... equipment 125 - - 125 accretion in carrying value of senior convertible notes ...Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
...The principal amount of the loan has been discounted to fair value for balance sheet presentation as a result of the below market interest rates. The accretion of the discount will cause an increase in the carrying amount of indebtedness, and in charges to interest expense, from December 31, 2008 to June 30, ...